
Glimirid1 mg
ACI Limited
Glimepiride is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
Glimepiride is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Its evidence-based uses can be classified as follows:
Glimepiride is not an antibiotic and has no anti-infective use.
| Step | Dose | Notes |
|---|---|---|
| Initial dose | 1-2 mg once daily | Start at 1 mg once daily in elderly patients or those at higher risk of hypoglycemia (e.g., renal impairment) |
| Titration | Increase by 1-2 mg at intervals of 1-2 weeks | Based on blood glucose response; titrate conservatively |
| Usual maintenance dose | 1-4 mg once daily | Most patients achieve control within this range |
| Maximum dose | 8 mg once daily | Doses above 8 mg generally provide no additional benefit |
Glimepiride is not recommended for use in pediatric patients; safety and efficacy in children have not been established, and use in this population is generally avoided due to concerns about hypoglycemia and effects on body weight.
In patients with mild-to-moderate renal impairment, treatment should be initiated at 1 mg once daily with careful, conservative titration under close monitoring, as active metabolites of Glimepiride can accumulate, increasing hypoglycemia risk. Use with particular caution in severe renal impairment.
Pharmacokinetics of Glimepiride have not been extensively studied in hepatic impairment; use with caution, starting at a low dose, and monitor closely for hypoglycemia.
Glimepiride should be swallowed whole with a sufficient amount of liquid, immediately before or with the first main meal of the day, to reduce the risk of hypoglycemia. Doses should not be skipped, and meals should not be omitted after taking a dose.
The most common adverse effect associated with Glimepiride is hypoglycemia (low blood sugar), which can range from mild (sweating, tremor, hunger, palpitations) to severe (confusion, seizure, loss of consciousness) and requires prompt attention. Other reported side effects of Glimepiride include:
Patients should seek medical attention if severe skin reactions, signs of liver dysfunction (jaundice, dark urine), or unusual bleeding/bruising occur while taking Glimepiride.
Glimepiride is contraindicated in patients with:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.